The lancet market size has grown rapidly in recent years. It will grow from $2.8 billion in 2025 to $3.11 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to growing prevalence of diabetes, rising hospital infrastructure, increased awareness of blood testing, demand for point-of-care diagnostics, development of safety lancets.
The lancet market size is expected to see rapid growth in the next few years. It will grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to technological advancements in lancet design, adoption of homecare testing kits, integration with digital health platforms, expansion in emerging markets, increased regulatory support for safety devices. Major trends in the forecast period include miniaturization of medical devices, increased focus on patient safety, rising home healthcare adoption, growth in point-of-care diagnostics, eco-friendly & sustainable medical instruments.
The increasing prevalence of diabetes is anticipated to drive the expansion of the lancet market in the coming years. Diabetes is a chronic condition that affects the body’s ability to convert food into energy due to issues with insulin production or utilization. The rise in diabetes cases is mainly attributed to unhealthy lifestyle choices, including poor diet, physical inactivity, and higher rates of obesity, all of which contribute to insulin resistance and elevated blood sugar levels. Lancets play a crucial role in diabetes management by allowing regular blood glucose monitoring through safe and precise fingertip pricks, which is vital for effective diabetes control, early detection of glucose fluctuations, and timely modifications in medication, diet, or lifestyle to prevent complications. For example, in June 2024, the National Health Service (NHS), a UK-based government body, reported that in 2023, over half a million (549,000) additional individuals in England were identified as at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marked a significant increase from 3,065,825 in 2022, reflecting a rise of nearly 20%. Consequently, the rising prevalence of diabetes is fueling the growth of the lancet market.
Leading companies in the lancet market are focusing on innovative technologies such as total path control vertical-drive technology to enhance sampling accuracy and reduce pain during blood collection. This technology ensures that the lancet needle moves in a straight, vertical path during insertion and withdrawal, minimizing lateral movement to reduce tissue damage, vibration, and discomfort. This results in a more precise and comfortable blood sampling experience. For instance, in July 2025, SteriLance Medical (Suzhou) Inc., a China-based medical device firm, launched the OneStep lancing device and SoftSense lancets in Spain. This cap-free, hidden-needle lancing solution utilizes patent-protected total path control vertical-drive technology to offer virtually painless blood sampling while improving user safety. The device features a simplified four-step workflow - insert, twist, press, and eject - that reduces preparatory actions by approximately 70% compared to traditional lancing pens.
In August 2024, MTD S.p.A., an Italy-based medical device company, acquired the Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses of Ypsomed AG for an undisclosed sum. Through this acquisition, MTD S.p.A. aims to reinforce its global leadership in diabetes and obesity care by expanding its portfolio with advanced pen needles, lancets, and blood glucose monitoring systems. This move will boost production capacity and enable the company to enter high-growth markets like China and India while strengthening its footprint in North America and Europe. Ypsomed AG is a Switzerland-based manufacturer specializing in lancets and other self-injection devices.
Major companies operating in the lancet market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, SARSTEDT AG & Co. KG, B. Braun Melsungen AG, Owen Mumford Limited, Amkay Products Pvt. Ltd, NARANG MEDICAL LIMITED, GBUK GROUP LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, Sterimed Medical Devices Private Limited, MediPurpose Pte. Ltd, Carelife USA Inc., Shandong Lianfa Medical Plastic Products Co. Ltd, Ambimed Healthcare Private Limited, Greiner Bio-One International GmbH, Roche Diabetes Care GmbH, Ypsomed Holding AG, TaiDoc Technology Corporation, HTL STREFA S.A.
North America was the largest region in the lancet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lancet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lancet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the lancet market by increasing the cost of imported medical instruments, affecting supply chains and procurement processes, particularly for precision and safety lancets. Segments such as safety lancets and personal lancets are most impacted, while regions including North America and Europe face higher price pressures due to import dependencies. Despite these challenges, tariffs have encouraged some manufacturers to localize production and innovate cost-efficient designs, potentially benefiting domestic suppliers in the long term.
The lancet market research report is one of a series of new reports that provides lancet market statistics, including lancet industry global market size, regional shares, competitors with a lancet market share, detailed lancet market segments, market trends and opportunities, and any further data you may need to thrive in the lancet industry. This lancet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A lancet is a small, sharp, double-edged surgical instrument typically utilized for making quick, precise incisions or punctures in the skin, most commonly employed in procedures such as blood sampling, abscess drainage, or minor surgeries. It is an essential tool in both clinical and laboratory settings because of its ease of use, sterilizability, and effectiveness in minimizing tissue damage.
The main types of lancets comprise safety lancets, push button safety lancets, pressure-activated safety lancets, side button safety lancets, and personal lancets. A safety lancet is a single-use device featuring an automatic needle retraction mechanism designed to ensure safe, hygienic, and low-pain blood sampling while reducing the risk of needlestick injuries and cross-contamination. These lancets come in various gauge sizes, including 22 gauge and below, 23 to 33 gauge, and above 33 gauge. They are utilized in applications such as glucose testing, hemoglobin testing, coagulation testing, cholesterol testing, allergy testing, neonatal testing, and others. The primary end users of these lancets include hospitals, clinics, ambulatory surgery centers, homecare settings, and more.
The lancet market consists of sales of adjustable-depth lancets, pediatric lancets, blood glucose testing kits, multi-lancet devices, and heel lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The lancet market size is expected to see rapid growth in the next few years. It will grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to technological advancements in lancet design, adoption of homecare testing kits, integration with digital health platforms, expansion in emerging markets, increased regulatory support for safety devices. Major trends in the forecast period include miniaturization of medical devices, increased focus on patient safety, rising home healthcare adoption, growth in point-of-care diagnostics, eco-friendly & sustainable medical instruments.
The increasing prevalence of diabetes is anticipated to drive the expansion of the lancet market in the coming years. Diabetes is a chronic condition that affects the body’s ability to convert food into energy due to issues with insulin production or utilization. The rise in diabetes cases is mainly attributed to unhealthy lifestyle choices, including poor diet, physical inactivity, and higher rates of obesity, all of which contribute to insulin resistance and elevated blood sugar levels. Lancets play a crucial role in diabetes management by allowing regular blood glucose monitoring through safe and precise fingertip pricks, which is vital for effective diabetes control, early detection of glucose fluctuations, and timely modifications in medication, diet, or lifestyle to prevent complications. For example, in June 2024, the National Health Service (NHS), a UK-based government body, reported that in 2023, over half a million (549,000) additional individuals in England were identified as at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marked a significant increase from 3,065,825 in 2022, reflecting a rise of nearly 20%. Consequently, the rising prevalence of diabetes is fueling the growth of the lancet market.
Leading companies in the lancet market are focusing on innovative technologies such as total path control vertical-drive technology to enhance sampling accuracy and reduce pain during blood collection. This technology ensures that the lancet needle moves in a straight, vertical path during insertion and withdrawal, minimizing lateral movement to reduce tissue damage, vibration, and discomfort. This results in a more precise and comfortable blood sampling experience. For instance, in July 2025, SteriLance Medical (Suzhou) Inc., a China-based medical device firm, launched the OneStep lancing device and SoftSense lancets in Spain. This cap-free, hidden-needle lancing solution utilizes patent-protected total path control vertical-drive technology to offer virtually painless blood sampling while improving user safety. The device features a simplified four-step workflow - insert, twist, press, and eject - that reduces preparatory actions by approximately 70% compared to traditional lancing pens.
In August 2024, MTD S.p.A., an Italy-based medical device company, acquired the Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses of Ypsomed AG for an undisclosed sum. Through this acquisition, MTD S.p.A. aims to reinforce its global leadership in diabetes and obesity care by expanding its portfolio with advanced pen needles, lancets, and blood glucose monitoring systems. This move will boost production capacity and enable the company to enter high-growth markets like China and India while strengthening its footprint in North America and Europe. Ypsomed AG is a Switzerland-based manufacturer specializing in lancets and other self-injection devices.
Major companies operating in the lancet market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, SARSTEDT AG & Co. KG, B. Braun Melsungen AG, Owen Mumford Limited, Amkay Products Pvt. Ltd, NARANG MEDICAL LIMITED, GBUK GROUP LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, Sterimed Medical Devices Private Limited, MediPurpose Pte. Ltd, Carelife USA Inc., Shandong Lianfa Medical Plastic Products Co. Ltd, Ambimed Healthcare Private Limited, Greiner Bio-One International GmbH, Roche Diabetes Care GmbH, Ypsomed Holding AG, TaiDoc Technology Corporation, HTL STREFA S.A.
North America was the largest region in the lancet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lancet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lancet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the lancet market by increasing the cost of imported medical instruments, affecting supply chains and procurement processes, particularly for precision and safety lancets. Segments such as safety lancets and personal lancets are most impacted, while regions including North America and Europe face higher price pressures due to import dependencies. Despite these challenges, tariffs have encouraged some manufacturers to localize production and innovate cost-efficient designs, potentially benefiting domestic suppliers in the long term.
The lancet market research report is one of a series of new reports that provides lancet market statistics, including lancet industry global market size, regional shares, competitors with a lancet market share, detailed lancet market segments, market trends and opportunities, and any further data you may need to thrive in the lancet industry. This lancet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A lancet is a small, sharp, double-edged surgical instrument typically utilized for making quick, precise incisions or punctures in the skin, most commonly employed in procedures such as blood sampling, abscess drainage, or minor surgeries. It is an essential tool in both clinical and laboratory settings because of its ease of use, sterilizability, and effectiveness in minimizing tissue damage.
The main types of lancets comprise safety lancets, push button safety lancets, pressure-activated safety lancets, side button safety lancets, and personal lancets. A safety lancet is a single-use device featuring an automatic needle retraction mechanism designed to ensure safe, hygienic, and low-pain blood sampling while reducing the risk of needlestick injuries and cross-contamination. These lancets come in various gauge sizes, including 22 gauge and below, 23 to 33 gauge, and above 33 gauge. They are utilized in applications such as glucose testing, hemoglobin testing, coagulation testing, cholesterol testing, allergy testing, neonatal testing, and others. The primary end users of these lancets include hospitals, clinics, ambulatory surgery centers, homecare settings, and more.
The lancet market consists of sales of adjustable-depth lancets, pediatric lancets, blood glucose testing kits, multi-lancet devices, and heel lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Lancet Market Characteristics
3. Lancet Market Supply Chain Analysis
4. Global Lancet Market Trends and Strategies
5. Lancet Market Analysis of End Use Industries
7. Global Lancet Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Lancet Total Addressable Market (TAM) Analysis for the Market
9. Lancet Market Segmentation
22 Gauze and Below, 23 Gauze -33 Gauze, Above 33 Gauze
10. Lancet Market Regional and Country Analysis
11. Asia-Pacific Lancet Market
12. China Lancet Market
13. India Lancet Market
14. Japan Lancet Market
15. Australia Lancet Market
16. Indonesia Lancet Market
17. South Korea Lancet Market
18. Taiwan Lancet Market
19. South East Asia Lancet Market
20. Western Europe Lancet Market
21. UK Lancet Market
22. Germany Lancet Market
23. France Lancet Market
24. Italy Lancet Market
25. Spain Lancet Market
26. Eastern Europe Lancet Market
27. Russia Lancet Market
28. North America Lancet Market
29. USA Lancet Market
30. Canada Lancet Market
31. South America Lancet Market
32. Brazil Lancet Market
33. Middle East Lancet Market
34. Africa Lancet Market
36. Lancet Market Competitive Landscape and Company Profiles
37. Lancet Market Other Major and Innovative Companies
40. Lancet Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Lancet Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses lancet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for lancet? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lancet market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Safety Lancet; Push Button Safety Lancet; Pressure Activated Safety Lancet; Side Button Safety Lancet; Personal Lancet2) By Gauze Size: 22 Gauze And Below; 23 Gauze -33 Gauze; Above 33 Gauze
3) By Application: Glucose Testing; Hemoglobin Testing; Coagulation Testing; Cholesterol Testing; Allergy Testing; Neonatal Testing; Other Applications
4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Homecare Settings; Other End Users
Subsegments:
1) By Safety Lancet: Needle Lancet; Blade Lancet; Microneedle Safety Lancets2) By Push Button Safety Lancet: Fixed Depth Push Button Lancet; Adjustable Depth Push Button Lancet
3) By Pressure Activated Safety Lancet: Contact Activated Lancet; Spring-Loaded Pressure Lancet
4) By Side Button Safety Lancet: Retractable Needle Side Button Lancet; Non-Retractable Needle Side Button Lancet
5) By Personal Lancet: Reusable Personal Lancet; Single-Use Personal Lancet
Companies Mentioned: Cardinal Health Inc.; F. Hoffmann-La Roche Ltd; Abbott Laboratories; Becton Dickinson and Company; Terumo Corporation; SARSTEDT AG & Co. KG; B. Braun Melsungen AG; Owen Mumford Limited; Amkay Products Pvt. Ltd; NARANG MEDICAL LIMITED; GBUK GROUP LIMITED; ARKRAY HEALTHCARE PRIVATE LIMITED; Sterimed Medical Devices Private Limited; MediPurpose Pte. Ltd; Carelife USA Inc.; Shandong Lianfa Medical Plastic Products Co. Ltd; Ambimed Healthcare Private Limited; Greiner Bio-One International GmbH; Roche Diabetes Care GmbH; Ypsomed Holding AG; TaiDoc Technology Corporation; HTL STREFA S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Lancet market report include:- Cardinal Health Inc.
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Becton Dickinson and Company
- Terumo Corporation
- SARSTEDT AG & Co. KG
- B. Braun Melsungen AG
- Owen Mumford Limited
- Amkay Products Pvt. Ltd
- NARANG MEDICAL LIMITED
- GBUK GROUP LIMITED
- ARKRAY HEALTHCARE PRIVATE LIMITED
- Sterimed Medical Devices Private Limited
- MediPurpose Pte. Ltd
- Carelife USA Inc.
- Shandong Lianfa Medical Plastic Products Co. Ltd
- Ambimed Healthcare Private Limited
- Greiner Bio-One International GmbH
- Roche Diabetes Care GmbH
- Ypsomed Holding AG
- TaiDoc Technology Corporation
- HTL STREFA S.A.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.11 Billion |
| Forecasted Market Value ( USD | $ 4.71 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
